Is increased chronological age a contraindication to debulking surgery for elderly patients with advanced ovarian cancer?

被引:1
|
作者
Park, Soo Jin [1 ]
Mun, Jaehee [1 ]
Yim, Ga Won [2 ]
Lee, Maria [1 ]
Chung, Hyun Hoon [1 ]
Kim, Jae Weon [1 ]
Park, Noh Hyun [1 ]
Song, Yong Sang [1 ]
Kim, Hee Seung [1 ]
机构
[1] Seoul Natl Univ, Dept Obstet & Gynecol, Coll Med, 101 Daehak Ro, Seoul 03080, South Korea
[2] Dongguk Univ, Dept Obstet & Gynecol, Coll Med, Goyang, South Korea
关键词
Aged; ovarian neoplasm; postoperative complications; prognosis; surgical procedure; CYTOREDUCTIVE SURGERY; CHEMOTHERAPY; MORBIDITY; COMORBIDITY; TOXICITY; OUTCOMES; RISK;
D O I
10.1080/01443615.2022.2112021
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
We collected data of elderly patients aged 65 years and older who underwent debulking surgery for advanced ovarian cancer in order to explore the impact of old age on surgical outcomes and complications. A total of 120 patients were classified as follows: group 1, 65-69 years (n = 58); group 2, 70-74 years (n = 38); group 3, 75-79 years (n = 17); group 4, >= 80 years (n = 7). There were no differences in most of the characteristics, surgical extent and outcomes, and postoperative complications between the four groups, whereas polypharmacy was more common (6 vs. 5-16; p=.02) and operation time was shorter (median, 194 vs. 285-330 min; p=.02) in group 4. Factors related to frailty rather than age, polypharmacy, preoperative albumin level, estimated blood loss and transfusion increased the risk of postoperative complications. Thus, the impact of old age on surgical extent, outcomes and postoperative complications may be minimal in elderly patients with advanced ovarian cancer. Impact Statement What is already known on this subject? Optimal debulking surgery is a significant factor in improving the prognosis of ovarian cancer but it is not easy to perform such radical surgery on elderly patients in fear of increasing surgical morbidity and mortality. Some studies suggest that underlying comorbidities may be a stronger contributing factor to increasing such risk rather than old age although there is not enough evidence yet. What do the results of this study add? Through this study, we could see that increased age is not the determining cause of increased morbidity and mortality in elderly patients who undergo optimal debulking surgery in ovarian cancer. There are other aspects describing a patient's health status that can predict prognosis better rather than age. What are the implications of these findings for clinical practice and/or further research? Old age need not be a contraindication when performing optimal debulking surgery in elderly patients with advanced ovarian cancer.
引用
收藏
页码:3254 / 3259
页数:6
相关论文
共 50 条
  • [21] Prognostic significance of systematic lymphadenectomy as part of primary debulking surgery in patients with advanced ovarian cancer
    Chang, Suk-Joon
    Bristow, Robert E.
    Ryu, Hee-Sug
    GYNECOLOGIC ONCOLOGY, 2012, 126 (03) : 381 - 386
  • [22] Debulking Surgery for Incompletely Operated Advanced Epithelial Ovarian Carcinoma
    Gultekin, Murat
    Dursun, Polat
    Dogan, Nasuh U.
    Kolusari, Ali
    Yuce, Kunter
    Ayhan, Ali
    JOURNAL OF SURGICAL ONCOLOGY, 2009, 100 (03) : 258 - 260
  • [23] Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer
    Vergote, Ignace
    Amant, Frederic
    Kristensen, Gunnar
    Ehlen, Tom
    Reed, Nick S.
    Casado, Antonio
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S88 - S92
  • [24] Case report: Minimally invasive primary debulking surgery for advanced stage epithelial ovarian cancer
    Wolf, Jennifer
    Goncalves, Nicole
    Alagkiozidis, Ioannis
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [25] Total rectosigmoidectomy versus partial rectal resection in primary debulking surgery for advanced ovarian cancer
    Plotti, F.
    Montera, R.
    Aloisi, A.
    Scaletta, G.
    Capriglione, S.
    Luvero, D.
    Nardone, C. De Cicco
    Basile, S.
    Panici, P. Benedetti
    Angioli, R.
    EJSO, 2016, 42 (03): : 383 - 390
  • [26] Survival in stage IV ovarian cancer with increased use of debulking surgery and bevacizumab
    Verleye, Leen
    Castanares-Zapatero, Diego
    Devos, Carl
    De Gendt, Cindy
    Silversmit, Geert
    Van Damme, Nancy
    Hulstaert, Frank
    Thiry, Nancy
    Neyt, Mattias
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (04) : 543 - 548
  • [27] Interval debulking surgery for advanced epithelial ovarian cancer: A Cochrane systematic review
    Tangjitgamol, Siriwan
    Manusirivithaya, Sumonmal
    Laopaiboon, Malinee
    Lumbiganon, Pisake
    GYNECOLOGIC ONCOLOGY, 2009, 112 (01) : 257 - 264
  • [28] Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer
    Suidan, Rudy S.
    Leitao, Mario M., Jr.
    Zivanovic, Oliver
    Gardner, Ginger J.
    Roche, Kara C. Long
    Sonoda, Yukio
    Levine, Douglas A.
    Jewell, Elizabeth L.
    Brown, Carol L.
    Abu-Rustum, Nadeem R.
    Charlson, Mary E.
    Chi, Dennis S.
    GYNECOLOGIC ONCOLOGY, 2015, 138 (02) : 246 - 251
  • [29] Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients
    Jorgensen, Trine Lembrecht
    Teiblum, Sandra
    Paludan, Merete
    Poulsen, Laurids Ostergaard
    Jorgensen, Anni Young Stensgard
    Bruun, Karin Herskind
    Hallas, Jesper
    Herrstedt, Jorn
    GYNECOLOGIC ONCOLOGY, 2012, 127 (02) : 367 - 374
  • [30] Increased ERCC1 Protein Expression Is Associated with Suboptimal Debulking in Advanced Epithelial Ovarian Cancer
    Lin, Feili
    Lin, Kaiqing
    Xie, Xing
    Zhou, Caiyun
    ANTICANCER RESEARCH, 2010, 30 (06) : 2447 - 2452